Mankind Pharma Limited

BSE
MANKIND
paper.types.company
Rentabilité sur six mois: -4.08%
Rendement en dividendes: 0%
Secteur: Healthcare

2 459 ₹

+5.15 ₹ +0.2099%
1990 ₹
3001.3 ₹

paper.min_max_per_year

Calendrier des promotions Mankind Pharma Limited

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise Mankind Pharma Limited

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. It also offers consumer healthcare products, such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and antiacne preparations.

plus de détails
The company offers its products primarily under the Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar brand names. In addition, it engages in the trading and exporting of pharmaceutical and health care products; manufacturing of packing materials and consumer goods; real estate, leasing, and hospitality businesses; and provision of IT services. Mankind Pharma Limited was incorporated in 1991 and is based in New Delhi, India.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

Paramètres de base

ISIN
INE634S01028
Industry
Pharmaceuticals
Sector
Health Care
Валюта
inr
Сайт
lien
Tous les paramètres

Grade

Sous-estimation
Nom Signification Grade
P/S 0 0
P/BV 0 0
P/E 0 0
Efficacité
Nom Signification Grade
ROA 0 0
ROE 0 0
ROIC 0 0
Dividendes
Nom Signification Grade
Rendement en dividendes 0 0
DSI 0 0
Croissance moyenne du dividende 0 0
Devoir
Nom Signification Grade
Debt/EBITDA 0 10
Debt/Ratio 0 10
Debt/Equity 0 10
Impulsion de croissance
Nom Signification Grade
Rentabilité Revenue, % 0 0
Rentabilité Ebitda, % 0 0
Rentabilité EPS, % 0 0
Plus de détails

paper.price.prices

Prix Common.min. Common.max. Changement paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 2 453.85 ₹ 0 ₹ 0 ₹ 0.21 % 0 % 0 %
common.calendar.number_days.7d 2 533.05 ₹ 0 ₹ 0 ₹ -2.92 % 0 % 0 %
common.calendar.number_days.30d 2 559.2 ₹ 2 431.1 ₹ 2 568.3 ₹ -3.92 % 0 % 0 %
common.calendar.number_days.90d 2 337.05 ₹ 2 146.45 ₹ 2 602.8 ₹ 5.22 % 0 % 0 %
common.calendar.number_days.180d 2 563.65 ₹ 2 146.45 ₹ 3 001.3 ₹ -4.08 % 0 % 0 %
common.calendar.number_days.1y 2 125 ₹ 1 990 ₹ 3 001.3 ₹ 15.72 % 0 % 0 %
common.calendar.number_days.3y 0 ₹ 1 322.55 ₹ 3 001.3 ₹ 0 % 0 % 0 %
common.calendar.number_days.5y 0 ₹ 1 322.55 ₹ 3 001.3 ₹ 0 % 0 % 0 %
common.calendar.number_days.10y 0 ₹ 1 322.55 ₹ 3 001.3 ₹ 0 % 0 % 0 %
common.calendar.number_days.ytd 2 640.3 ₹ 2 146.45 ₹ 2 938.25 ₹ -6.87 % 0 % 0 %

Entreprises similaires

P/E & P/BVEV/Ebitda & Debt/Ebitda


Gestion d'entreprise

Superviseur Titre d'emploi Paiement Année de naissance
Mr. Ramesh C. Juneja Executive Chairman 259.29M 1955 (70 années)
Mr. Sheetal Arora CEO & Whole-Time Director 154.56M 1975 (50 années)
Mr. Rajeev Juneja Vice Chairman & MD 288.82M 1965 (60 années)
Mr. Ashutosh Dhawan MBA Chief Financial Officer N/A 1968 (57 années)
Mr. Arjun Juneja Chief Operating Officer N/A 1986 (39 années)
Mr. Pramod Gokhale President - Group Chief Information Officer N/A 1971 (54 année)
Dr. Anil Kumar Chief Scientific Officer (Research Centre) N/A 1953 (72 année)
Mr. Satish Kumar Sharma Whole-Time Director 1973 (52 année)
Mr. Chanakya Juneja Director of Technology
Mr. Abhishek Agarwal Head of Investor Relations

Informations sur l'entreprise

Adresse: India, New Delhi, 262. Okhla Industrial Estate - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.mankindpharma.com